Egenesis raises $191m to bring genetically edited pig organs to human trials
Longevity Technology - 05-Sep-2024Xenotransplantation biotech advances groundbreaking pig kidney transplants
Join the club for FREE to access the whole archive and other member benefits.
Company that develops effective human transplantable organs, tissues and cells.
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation.
Visit website: https://www.egenesisbio.com/
Details last updated 11-Dec-2019
Xenotransplantation biotech advances groundbreaking pig kidney transplants
Possible to breed pigs to harvest their organs to meet the demand for new tissue